Nebenwirkungen · Trixeo Aerosphere
Trixeo Aerosphere 5 micrograms/14.4 micrograms/160 micrograms pressurised inhalation, suspension · Abschnitt 4.8 · PDF-Seite 23
HOS-143839 · Präparat HOS-099046
System Organ Class Preferred term Frequency Infections and infestations Urinary tract infection Common Oral candidiasis Immune system disorders Hypersensitivity Uncommon Angioedema Not known Endocrine disorders Signs or symptoms of systemic Very rare glucocorticosteroid effects, e.g. hypofunction of the adrenal gland Metabolism and nutrition Hyperglycaemia Common disorders Psychiatric disorders Anxiety Common Insomnia Depression Uncommon Agitation Restlessness Nervousness Abnormal behaviour Very rare Nervous system disorders Headache Common Dizziness Uncommon Tremor Eye disorders Glaucoma Not known Cataract Vision blurred (see section 4.4) Cardiac disorders Palpitations Common Angina pectoris Uncommon Cardiac arrhythmias (atrial fibrillation, supraventricular tachycardia and extrasystoles) Tachycardia Respiratory, thoracic and Dysphonia Common mediastinal disorders Cough Bronchospasm Uncommon Throat irritation Gastrointestinal disorders Nausea Common Dry mouth Uncommon Skin and subcutaneous Bruising Uncommon tissue disorders Musculoskeletal and Muscle spasms Common connective tissue disorders Renal and urinary Urinary retention Uncommon disorders
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-23T11:31:00Z · SHA-256 122589165768579147ca9cf954ed9b9abdf94493426b27543d7d354a1b8a443e · Passage 9587d072fc422d6dd46164c453e8de9dd15c952283d9e1e783887f246ab06fca · Zeichen 928–3664 im Abschnitt